Determination of medical abortion success by women and community health volunteers in Nepal using a symptom checklist

被引:3
作者
Andersen, Kathryn L. [1 ]
Fjerstad, Mary
Basnett, Indira
Neupane, Shailes [2 ]
Acre, Valerie [1 ]
Sharma, Sharad
Jackson, Emily
机构
[1] Ipas, 300 Market St,Suite 200, Chapel Hill, NC 27516 USA
[2] Valley Res Grp VaRG, Lalitpur, Nepal
关键词
Medical abortion; Abortion; Nepal; Self-assessment; Community health volunteers; FOLLOW-UP; BUCCAL MISOPROSTOL; MIFEPRISTONE; ALTERNATIVES; PREGNANCY; ULTRASOUND;
D O I
10.1186/s12884-018-1804-3
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: We sought to determine if female community health volunteers (FCHVs) and literate women in Nepal can accurately determine success of medical abortion (MA) using a symptom checklist, compared to experienced abortion providers. Methods: Women undergoing MA, and FCHVs, independently assessed the success of each woman's abortion using an 8-question symptom checklist. Any answers in a red-shaded box indicated that the abortion may not have been successful. Women's/FCHVs' assessments were compared to experienced abortion providers using standard of care. Results: Women's (n = 1153) self-assessment of MA success agreed with abortion providers' determinations 85% of the time (positive predictive value = 90, 95% CI 88, 92); agreement between FCHVs and providers was 82% (positive predictive value = 90, 95% CI 88, 92). Of the 92 women (8%) requiring uterine evacuation with manual vacuum aspiration (n = 84, 7%) or medications (n = 8, 0.7%), 64% self-identified as needing additional care; FCHVs identified 61%. However, both women and FCHVs had difficulty recognizing that an answer in a red-shaded box indicated that the abortion may not have been successful. Of the 453 women with a red-shaded box marked, only 35% of women and 41% of FCHVs identified the need for additional care. Conclusion: Use of a checklist to determine MA success is a promising strategy, however further refinement of such a tool, particularly for low-literacy settings, is needed before widespread use.
引用
收藏
页数:6
相关论文
共 26 条
[21]   A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation [J].
Tang, OS ;
Chan, CCW ;
Ng, EHY ;
Lee, SWH ;
Ho, PC .
HUMAN REPRODUCTION, 2003, 18 (11) :2315-2318
[22]  
TEMPLETON A, 1990, BRIT J OBSTET GYNAEC, V97, P480
[23]  
VANLOOK PFA, 1993, BRIT MED J, V307, P532
[24]  
WHO (World Health Organization), 2012, TRENDS MAT MORT 1990
[25]  
Winikoff B, 2012, OBSTET GYNECOL, V120, P1070, DOI [10.1097/AOG.0b013e31826c315f, http://10.1097/AOG.0b013e31826c315f]
[26]  
World Health Organization, 2015, Health worker roles in providing safe abortion care and post-abortion contraception